Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2504 of 5804
-
Can a pill help kids with insomnia sleep better?
Symptom relief Recruiting nowThis is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female pediatric participants with insomnia disorder.
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Veterans use smartwatch and cycling to tackle PTSD
Symptom relief ENROLLING_BY_INVITATIONThe goal of this study is to test the effectiveness of a stress self-management mobile health system (smartphone app + wearable sensor) alongside an intense physical cycling intervention to reduce symptoms of stress in a veteran population. The main questions this study aims to a…
Phase: NA • Sponsor: Texas A&M University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Magic mushroom chemical under the microscope: can brain scans reveal how it fights depression?
Knowledge-focused Recruiting nowLimit: 5000 characters. Psilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. In healthy volunteers, the psychedelic effects of psilocybin …
Phase: PHASE2 • Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New patch could cut opioid addiction after ankle surgery
Symptom relief Recruiting nowAddictive full-agonist opioids, like oxycodone and hydrocodone, are often used to treat pain after surgery. However, these full-agonist opioids can be very addictive. After ankle fracture surgery, about 1 in 5 patients that did not take opioids before surgery become addicted to o…
Phase: PHASE4 • Sponsor: Jenna-Leigh Wilson • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Can an AI chatbot cure social anxiety? new study tests smartphone therapy
Symptom relief OngoingThis pilot study compares two 4-week, smartphone-based treatments for social anxiety: one uses a psychodynamic therapy approach and the other uses a cognitive behavioral therapy approach. Both treatments are guided by an AI assistant rather than a human therapist. The AI assistan…
Phase: NA • Sponsor: Stockholm University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Yale study tests sleep fix to kick smoking habit
Disease control Recruiting nowThe study aims to investigate whether behavioral interventions promote cessation in adult smokers by ameliorating negative emotions and improving self-control and identify the neural markers of these effects.
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Dance therapy shows promise for breast cancer patients
Symptom relief OngoingThis study aims to evaluate the effects of a dance program on physical and psychological outcomes in women undergoing breast cancer treatment. It is a randomized clinical trial with participants allocated into two groups: Dance Program Group (DPG) and Control Group (CG). The DPG …
Phase: NA • Sponsor: Federal University of Maranhao • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Can a WhatsApp program stop skin cancer in hispanics?
Prevention Recruiting nowHypothesis: More than 80% of the participants (n=40) will complete the intervention at three month (intervention completion) and the six month follow-up (retention rate as feasibility). More than 70% of the participants will report high overall study satisfaction (acceptability) …
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
Mind over movement: remote therapy shows promise for MS balance
Symptom relief CompletedThis study aims to investigate the effects of the treatment combination consisting of motor imagery and action observation therapy on balance, functional mobility, lower extremity muscle strength, fatigue and quality of life.
Phase: NA • Sponsor: Inonu University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can chicken collagen beat glucosamine for knee pain?
Symptom relief OngoingThis randomized, double-blind, placebo-controlled clinical study evaluates the efficacy of Native CT-II® (undenatured type II collagen) in individuals with knee osteoarthritis using a parallel design.Participants are assigned to one of three groups: Group 1 receives Native CT-II…
Phase: NA • Sponsor: Vedic Lifesciences Pvt. Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Music as medicine: jazz and reggae tested for gut pain relief
Symptom relief OngoingChronic pain is a common complaint in inflammatory bowel disease (IBD). Compounding these concerns, opioid analgesics are frequently used to treat severe acute pain. An estimated 30% of chronic pain patients due to IBD report opioid use. Those who continue to use opioids can deve…
Phase: NA • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New gum fix could spare patients from tissue grafts
Disease control Recruiting nowtreatment of miller class III RT2 gingival recession using modified vista technique using connective tissue graft vs albumin PRF
Phase: PHASE2, PHASE3 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Experimental combo targets Tough-to-Treat colorectal cancer
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of abemaciclib in combination with 5-fluorouracil and how well it works in treating patients with colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic)…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New cancer drug MT-4561 enters first human tests
Disease control Recruiting nowThis is a First In Human (FIH), multicenter, open-label, Phase I/II study to evaluate safety, tolerability, Pharmacokinetics (PK), pharmacodynamics, and efficacy of MT-4561 in patients with advanced solid tumors. This study will be conducted in 3 parts. Part 1 is aimed at evalua…
Phase: PHASE1, PHASE2 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Robot teachers take on dementia: 8-Week course shows promise
Prevention CompletedThe purpose of this study is to intervene in the cognitive functions of the community elderly through the "Robot Dementia Prevention Course" training. It is expected that through the eight-week course design activities, the cognitive functions, social activities, emotional manage…
Phase: NA • Sponsor: National Taiwan Normal University • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Real-world data: luspatercept may cut transfusion needs in MDS patients
Disease control CompletedThe purpose of this study is to evaluate the treatment patterns and clinical outcomes in adults with lower-risk MDS (LR-MDS) who were erythropoiesis-stimulating agents (ESA)-naïve and received luspatercept treatment in China
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New colorectal cancer drug candidate RPH-030 enters Head-to-Head trial
Disease control Recruiting nowThe primary objective of this study is to demonstrate equivalence of pharmacokinetic properties, and comparability of safety and immunogenicity parameters of RPH-030 and Vectibix® following a single (first) intravenous administration to patients with mCRC with wild-type RAS genes…
Phase: PHASE1 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for tough blood cancers? early trial of CG009301 begins
Disease control Recruiting nowThe goal of this clinical trial is to learn about the safety of drug CG009301. It also learns if drug CG009301 works to treat in Participants with relapsed or refractory adult haematological malignancies. The main question\[s\] it aims to answer are: 1. To determine the maximum…
Phase: PHASE1 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Which therapy helps stroke survivors walk again? new study compares PNF and mCIMT
Symptom relief CompletedStroke, which is frequently characterized by weakness, poor balance, and decreased mobility that impede independence in everyday activities, has been identified as a major cause of long-term impairment globally. There have been reports of an increasing number of stroke survivors …
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can therapy help pregnant women stay on HIV prevention? new study aims to find out.
Disease control Recruiting nowPregnant women in South Africa (SA) are at high risk of HIV acquisition. Pre-exposure prophylaxis (PrEP) use during pregnancy is both safe and effective in preventing HIV. However, posttraumatic stress (associated with intimate partner violence and/or other traumas) and depressio…
Phase: NA • Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC